Search
  • The Cure CJD Campaign

Patient of University College London Hospitals NHS Foundation Trust (UCLH) to be given CJD treatment



In a world-first, a patient of University College London Hospitals NHS Foundation Trust (UCLH) is set to be given a pioneering treatment for Creutzfeldt-Jakob disease (CJD). UCLH is set to give the antibody to a patient for the first time after a judge in the Court of Protection today confirmed that it is lawful and in the patient’s best interests to receive the unlicensed treatment.


UCLH has created an antibody (PRN100) that binds tightly to normal proteins in the brain, stopping the abnormal prions from attaching themselves to healthy proteins, thus preventing them from causing damage to the brain.


For further information please visit: https://www.uclh.nhs.uk/News/Pages/PrionCJD.aspx?fbclid=IwAR1qaC3FWhcH9P8LX2NgrPJla3gc4kcvS3e4rr61XPRw49RHWJ11vzbkZO4

39 views
FOLLOW US 
  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon
CONTACT US

For enquiries regarding The Cure CJD Campaign, please email: curecjdcampaign@gmail.com

For medical enquiries, or enquiries related to the disease, please contact The National Prion Clinic: uclh.prion.help@nhs.net

© 2018 The Cure CJD Campaign. A fund within UCLH Charity. Registered Charity No: 1165398